Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis - a systematic review (Q35658597)

9 August 2017

1 reference

title

Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis - a systematic review (English)

1 reference

9 August 2017

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26058321 AND SRC:MED&resulttype=core&format=json

13 June 2020

author name string

R Dersch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26058321 AND SRC:MED&resulttype=core&format=json

13 June 2020

S Schmidt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26058321 AND SRC:MED&resulttype=core&format=json

13 June 2020

H Sommer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26058321 AND SRC:MED&resulttype=core&format=json

13 June 2020

S Rauer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26058321 AND SRC:MED&resulttype=core&format=json

13 June 2020

J J Meerpohl

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26058321 AND SRC:MED&resulttype=core&format=json

13 June 2020

publication date

8 June 2015

1 reference

European Journal of Neurology

9 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26058321 AND SRC:MED&resulttype=core&format=json

13 June 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26058321 AND SRC:MED&resulttype=core&format=json

13 June 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26058321 AND SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

1249-1259

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26058321 AND SRC:MED&resulttype=core&format=json

Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology

13 June 2020

cites work

1 reference

Antiscience and ethical concerns associated with advocacy of Lyme disease

21 January 2018

1 reference

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

21 January 2018

1 reference

Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

An introduction to methodological issues when including non-randomised studies in systematic reviews on the effects of interventions

21 January 2018

1 reference

EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis

21 January 2018

1 reference

Efficacy and safety of pharmacological treatments for neuroborreliosis--protocol for a systematic review

21 January 2018

1 reference

GRADE guidelines: 3. Rating the quality of evidence

21 January 2018

1 reference

Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial

21 January 2018

1 reference

Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis

21 January 2018

1 reference

Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis

21 January 2018

1 reference

Cefotaxime versus penicillin in the late stage of Lyme disease--prospective, randomized therapeutic study.

21 January 2018

1 reference

Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study

21 January 2018

1 reference

Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis

21 January 2018

1 reference

The neurological complications of Borrelia burgdorferi in the New Forest area of Hampshire

21 January 2018

1 reference

Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors

21 January 2018

1 reference

European neuroborreliosis: neuropsychological findings 30 months post-treatment

21 January 2018

1 reference

European neuroborreliosis: quality of life 30 months after treatment

21 January 2018

1 reference

Treatment for the neurological complications of Lyme disease

21 January 2018

1 reference

Destructive chronic borrelia meningoencephalitis in a child untreated for 15 years

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ENE.12744

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26058321 AND SRC:MED&resulttype=core&format=json

13 June 2020

1 reference